<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/oai-pmh.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-09-22T13:08:57Z</responseDate>
  <request identifier="oai:www.ideals.illinois.edu:2142/19453" metadataPrefix="etdms" verb="GetRecord">https://www.ideals.illinois.edu/oai-pmh</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:www.ideals.illinois.edu:2142/19453</identifier>
        <datestamp>2023-07-10</datestamp>
        <setSpec>col_2142_5131</setSpec>
        <setSpec>col_2142_14789</setSpec>
        <setSpec>com_2142_5130</setSpec>
        <setSpec>com_2142_14788</setSpec>
        <setSpec>com_2142_8903</setSpec>
      </header>
      <metadata>
        <thesis xmlns="http://www.ndltd.org/standards/metadata/etdms/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.ndltd.org/standards/metadata/etdms/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdms11.xsd http://purl.org/dc/elements/1.1/ http://www.ndltd.org/standards/metadata/etdms/1.1/etdmsdc.xsd">
          <dc:contributor>Katzenellenbogen, John A.</dc:contributor>
          <dc:creator>Liu, Aijun</dc:creator>
          <dc:date>2011-05-07T12:08:02Z</dc:date>
          <dc:date>2011-05-07T12:08:02Z</dc:date>
          <dc:date>10000-01-01</dc:date>
          <dc:date>1991</dc:date>
          <dc:description>In order to develop androgen receptor (AR) based probes for in vivo imaging of prostatic cancer using positron emission tomography (PET), four pairs of 16$\beta$- and 16$\alpha$-fluoro androgens, as well as two 20-fluoro androgens have been synthesized. The fluorination was achieved mainly by nucleophilic fluoride displacement of a triflate or a spirocyclic sulfate precursor, prepared by multistep synthesis.</dc:description>
          <dc:description>Of the ten fluorinated androgens, 16$\beta$-F-DHT (1), 16$\beta$- and 16$\alpha$-F-Mib (5 and 6), 16$\beta$- and 16$\alpha$-F-MNT (7 and 8), 20-F-Mib (9), as well as 20-F-R1881 (10) were found to have high relative binding affinity for AR, 19%-53% of the potent androgen R1881. In most cases, the fluorination improved the binding selectivity of the androgens to AR vs. other steroid receptors and SBP, and the 16$\beta$-fluoro androgens have higher affinity than their corresponding 16$\alpha$-fluoro epimers. Other interesting structure-activity relationships were observed.</dc:description>
          <dc:description>Seven of these fluorinated androgens have been prepared in fluorine-18 labeled form, and their in vivo tissue distribution have been studied in estrogen-treated mature male rats. All seven fluorine-18 labeled androgens showed selective and blockable target tissue uptake: the prostate to blood and prostate to muscle ratios (at 4 h) were from 5 (20-F-R1881) to 30 (16$\alpha$-F-MNT), and the uptake in the unblocked animals were 2.5 (16$\beta$-F-Mib) to 5.3 (16$\alpha$-F-MNT and 20-F-MIb) fold higher than that in the blocked animals. Rapid in vivo defluorination was observed with three 16$\beta$-fluoro androgens (1, 3 and 7). Thus, we have synthesized the first fluorine-18 labeled androgens that have relative high binding affinity and selectivity for AR, and show selective target tissue uptake. It appears that 16$\beta$-F-F-Mib (5), 16$\alpha$-F-MNT (8) and 20-F-Mib (9) are the most promising candidates as in vivo imaging agents for prostatic cancer.</dc:description>
          <dc:description>Made available in DSpace on 2011-05-07T12:08:02Z (GMT). No. of bitstreams: 2
license.txt: 4922 bytes, checksum: 910b249b4beec47e7ab768910c8f966f (MD5)
9210898.pdf: 6800363 bytes, checksum: 9b818e792adf104faf626a8fa65b4b2c (MD5)
  Previous issue date: 1991</dc:description>
          <dc:description>Item marked as restricted to the 'UIUC Users [automated]' Group (id=2) by Howard Ding (hding2@illinois.edu) on 2011-05-07T14:37:04Z
Item is restricted indefinitely.</dc:description>
          <dc:description>Restriction data tranferred 2014-07-01T11:15:10-05:00
Original Data
Group with Access UIUC Users [automated]
Release Date: none
Reason: ETDs are only available to UIUC Users without author permission</dc:description>
          <dc:description>ETDs are only available to UIUC Users without author permission</dc:description>
          <dc:description>U of I Only</dc:description>
          <dc:identifier>AAI9210898</dc:identifier>
          <dc:identifier>(UMI)AAI9210898</dc:identifier>
          <dc:identifier>http://hdl.handle.net/2142/19453</dc:identifier>
          <dc:language>eng</dc:language>
          <dc:rights>Copyright 1991 Liu, Aijun</dc:rights>
          <dc:subject>Chemistry, Organic</dc:subject>
          <dc:subject>Chemistry, Pharmaceutical</dc:subject>
          <dc:subject>Health Sciences, Radiology</dc:subject>
          <dc:subject>Chemistry, Nuclear</dc:subject>
          <dc:title>Synthesis and evaluation of fluorine-18 labeled androgens as in vivo imaging agents for prostatic cancer using PET</dc:title>
          <dc:type>text</dc:type>
          <degree>
            <department>Chemistry</department>
            <discipline>Chemistry</discipline>
            <grantor>University of Illinois at Urbana-Champaign</grantor>
            <level>Dissertation</level>
            <name>Ph.D.</name>
          </degree>
        </thesis>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
